Hayashi Norio | The 1st Department Of Medicine Osaka University Medical School

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C
A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
Juvenile hepatocellular carcinoma with congestive liver cirrhosis
Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
Expression of Rab5a in hepatocellular carcinoma : Possible involvement in epidermal growth factor signaling
Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
Sequencing analysis of the terminal protein region in patients showing persistent remission of chronic hepatitis B
IS HELICOBACTER PYLORI-INDUCED ENLARGED FOLD GASTRITIS A HIGH-RISK FACTOR FOR GASTRIC CARCINOMA?
Pretreatment viral load and response to interferon therapy for liver cirrhosis caused by hepatitis C virus: a multicenter controlled study
Clinical efficacy and immunological effects of weekly administration of interferon-β in patients with type B chronic hepatitis
Effect of glycyrrhizin on viral replication and quasispecies in patients with type C chronic hepatitis
Binding cells of ^I-iodoamphetamine in rat liver
Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease : a multicenter experience
Cultured bone marrow cell local implantation accelerates healing of ulcers in mice
Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas
Hypervascular hepatocellular carcinoma : Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP
Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
New chemotherapy for patients with advanced hepatocellular carcinoma : Pilot study of β-interferon and doxorubicin one-shot intra-arterial chemotherapy
Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
Involvement of GBV-C/HGV in liver diseases in Japan
Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice
Endoscopic follow-up study of development of gastric antral vascular ectasia associated with liver cirrhosis
Changes in virus loads and precore mutations in chronic hepatitis B patients treated with 4 weeks of daily interferon alfa-2a therapy
Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C
Hepatitis C virus 1b(II) Infection and Development of Chronic Hepatitis, Liver Cirrhosis and Hepatocellular Carcinoma : a Case-Control Study in Japan
Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo
Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
SHORT-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR EARLY GASTRIC NEOPLASM : MULTICENTER SURVEY BY OSAKA UNIVERSITY ESD STUDY GROUP
Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group
The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
Differential alteration of CD56^ and CD56^ natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
Association of low serum adiponectin levels with erosive esophagitis in men : an analysis of 2405 subjects undergoing physical check-ups
Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin

もっと見る

スポンサーリンク